Life Science Comment

29 May 2008 - Coping with meltdown at the end of a NICE age

A NICE era is over! Time to sell in May and go away -- or stay away? In February 2008, AiLS looked for signs of an upturn only to..  More >>

29 February 2008 - A war of attrition.....

..or blood in the streets – what does the future hold? With darkness clouding the economic horizon in Autumn, the prospects for the lifescience..  More >>

28 September 2007 - Dark clouds on the horizon

Against a backdrop of turbulence in financial markets, rising oil prices and foreign currency gyrations it begins to look as if the honeymoon period of..  More >>

20 February 2007 - Preparing for the unexpected before it happens in turbulent markets

Seizing the opportunity Most (85%) pharma-biotech commentators say the biggest issue facing our industry is the R&D pipeline for innovative therapies..  More >>

18 November 2005 - France : Pharma outsourcing shaping up for the future

In light of developments at Fareva-PCG, we consider wider implications for pharmaceutical manufacturing in France, the outsourcing sector in..  More >>

11 November 2005 - Could body fat be good for blood cholesterol?

Scientists identify molecular link between body fat and blood lipids It's almost received wisdom that obesity has a negative influence on the level of..  More >>

12 November 2004 - BIO-Europe 2004. The blockbuster is dead - long live the blockbooster?

A France-based biopharmaco, with its drug delivery platform and an expanding product pipeline for immuno-compromised patients, confounds sceptics among..  More >>

28 July 2003 - Ankylosing spondylitis - a new class of treatment makes its fourth indication

Enbrel® - first biopharmaceutical to be approved by FDA for treatment of patients with active AS An inflammatory disease affecting the spine and other joints,..  More >>

18 July 2003 - New treatment slows progression of Parkinson's disease

Research gives Parkinson’s patients hope of a more effective treatment. A new drug has been found to slow the loss of nerve function in early Parkinson’s..  More >>

04 July 2003 - New gold-standard for beta-blockers in heart failure?

Report in THE LANCET suggests carvedilol as the definitive beta-blocker for CHF Calls for beta-blockers to be used ’more widely for heart failure in clinical..  More >>

30 June 2003 - Polypill - Winning combination for a lost cause?

Is a one-size-fits-all polypharmaceutical to slash cardiovascular disease incidence viable after prevention has already failed? A debate about an interventive..  More >>

25 June 2003 - Preventive medicine: FDA approves dual medication, lower risk of heart attack

Product with two medicines to help prevent heart attacks in people with heart disease - one step along the road to reducing the risk of developing heart..  More >>